[ad_1]
A group of experts advising the World Health Organization (WHO) has issued a strong recommendation against the use of hydroxychloroquine to treat COVID-19.
Guidance published in the British Medical Journal this week is based on the results of six trials with more than 6,000 participants, and “high-certainty evidence” found that the antimalarial drug “had little or no effect” on deaths and hospitalizations, while certainty evidence “found little effect on laboratory-confirmed SARS-CoV-2 infection.
UNITED STATES HOLDS PLASMA STUDY TO DEAL WITH COVID-19 MILD WHICH ARE ‘UNBELIEVABLE BENEFITS’
The drug is no longer seen as a “research priority,” the panel said. (iStock)
“The committee considers that this drug is no longer a research priority and that resources should rather be directed towards the evaluation of other more promising drugs to prevent COVID”, indicates the guide. The recommendations apply to anyone without COVID-19, whether or not they have been exposed to the virus.
“The panel felt that almost all people would not find this drug useful,” the guide continues. The recommendations are part of a “living guideline” open to updates, by WHO and support from MAGIC Evidence Ecosystem Foundation.
GET THE FOX NEWS APP
The international health agency announced last October that four drugs, including hydroxychloroquine, had “little or no effect” on hospitalized patients in a study.
Former President Trump told reporters in May 2020 that he was taking hydroxychloroquine to avoid contracting coronavirus. Trump added that he consulted the former White House doctor before starting the drug. Dr Sean Conley said in a statement: “After much discussion he and I had about the evidence for and against the use of hydroxychloroquine, we concluded that the potential benefits of the treatment outweighed the potential benefits of the treatment. relative risks. “
Andrew Reilly of Fox News contributed to this report.
[ad_2]
Source link